Business Context and Reporting Period
This Form 8-K Current Report was filed by Bruker Corporation on February 25, 2013. The filing reports a specific corporate governance event: the appointment of a new senior executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Anthony L. Mattacchione as Senior Vice President, Corporate Finance and Accounting, effective February 25, 2013. Mr. Mattacchione previously served as Chief Financial Officer of EMD Millipore Corporation (a subsidiary of Merck KGaA).
Compensation and Management Commentary
Management disclosed the following compensatory arrangements for the new appointee:
- Base Salary: $280,000 annually.
- Performance Bonus: Eligible for an annual bonus with a 2013 target level of $140,000, subject to proration from the commencement date.
- Equity Grant: Received an initial grant of options to purchase 40,000 shares of common stock under the Company's 2010 Incentive Compensation Plan.
The filing states there are no other arrangements or understandings regarding his selection and no transactions requiring reporting under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the exact vesting schedule and exercise price for the 40,000 stock options granted to Mr. Mattacchione.
- Confirm the specific performance metrics tied to the $140,000 bonus target.
- Review the Company's 2010 Incentive Compensation Plan to understand the terms of the equity grant.
- Check for any subsequent filings regarding the departure of the previous officer in this role.